Reclassification of eight Akkermansia muciniphila strains and description of Akkermansia massiliensis sp. nov. and Candidatus Akkermansia timonensis, isolated from human feces.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
16 12 2022
Historique:
received: 21 07 2022
accepted: 06 12 2022
entrez: 16 12 2022
pubmed: 17 12 2022
medline: 21 12 2022
Statut: epublish

Résumé

Akkermansia muciniphila is a human intestinal tract bacterium that plays an important role in the mucus layer renewal. Several studies have demonstrated that it is a modulator for gut homeostasis and a probiotic for human health. The Akkermansia genus contains two species with standing in nomenclature but their genomic diversity remains unclear. In this study, eight new Akkermansia sp. strains were isolated from the human gut. Using the digital DNA-DNA hybridization (dDDH), average nucleotide identity (ANI) and core genome-based phylogenetic analysis applied to 104 A. muciniphila whole genomes sequences, strains were reclassified into three clusters. Cluster I groups A. muciniphila strains (including strain ATCC BAA-835

Identifiants

pubmed: 36526682
doi: 10.1038/s41598-022-25873-0
pii: 10.1038/s41598-022-25873-0
pmc: PMC9758162
doi:

Substances chimiques

RNA, Ribosomal, 16S 0
DNA, Bacterial 0
Fatty Acids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21747

Informations de copyright

© 2022. The Author(s).

Références

PLoS One. 2015 Oct 22;10(10):e0135280
pubmed: 26491870
PeerJ. 2021 Apr 06;9:e10941
pubmed: 33868800
Gut. 2014 May;63(5):727-35
pubmed: 23804561
Cells. 2022 Jun 30;11(13):
pubmed: 35805168
Microb Cell Fact. 2021 Dec 4;20(1):219
pubmed: 34863163
Appl Environ Microbiol. 2006 Nov;72(11):7286-93
pubmed: 16980418
Front Microbiol. 2017 Jun 30;8:1221
pubmed: 28713349
Int J Syst Evol Microbiol. 2019 Jan;69(1A):S1-S111
pubmed: 26596770
Biosci Rep. 2019 Jun 18;39(6):
pubmed: 31147456
Int J Syst Evol Microbiol. 2016 Nov;66(11):4614-4620
pubmed: 27499019
Microorganisms. 2021 May 20;9(5):
pubmed: 34065217
Microorganisms. 2020 Nov 16;8(11):
pubmed: 33207645
Circulation. 2016 Jun 14;133(24):2434-46
pubmed: 27143680
Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19126-31
pubmed: 19855009
Gut. 2022 May;71(5):1020-1032
pubmed: 35105664
Clin Infect Dis. 2009 Aug 15;49(4):543-51
pubmed: 19583519
ISME J. 2022 Mar;16(3):630-641
pubmed: 34493810
Gut. 2018 May;67(5):891-901
pubmed: 28550049
Curr Microbiol. 2021 Aug;78(8):3313-3320
pubmed: 34165609
Gut. 2018 Aug;67(8):1445-1453
pubmed: 29269438
Can J Biochem Physiol. 1959 Aug;37(8):911-7
pubmed: 13671378
Appl Environ Microbiol. 2007 Dec;73(23):7767-70
pubmed: 17933936
Int J Syst Evol Microbiol. 2015 Jun;65(Pt 6):1929-1934
pubmed: 25736410
Curr Opin Pharmacol. 2019 Dec;49:1-5
pubmed: 31015106
Bioinformatics. 2015 Nov 15;31(22):3691-3
pubmed: 26198102
Nucleic Acids Res. 2015 Aug 18;43(14):6761-71
pubmed: 26150420
Appl Environ Microbiol. 2016 Dec 1;82(23):6983-6993
pubmed: 27663027
Cancer Immunol Res. 2021 Oct;9(10):1111-1124
pubmed: 34389559
Gut Microbes. 2022 Jan-Dec;14(1):2025017
pubmed: 35263215
Int J Syst Evol Microbiol. 2020 Jul;70(7):4091-4097
pubmed: 32628103
New Microbes New Infect. 2018 Jun 21;26:63-72
pubmed: 30258635
ISME J. 2012 Aug;6(8):1449-58
pubmed: 22437156
Sci Rep. 2021 Apr 27;11(1):9073
pubmed: 33907216
New Microbes New Infect. 2016 Jan 11;10:66-76
pubmed: 26937282
Int J Syst Evol Microbiol. 2004 Sep;54(Pt 5):1469-1476
pubmed: 15388697
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
J Clin Microbiol. 1991 Oct;29(10):2197-203
pubmed: 1939571
Brief Bioinform. 2019 Jul 19;20(4):1576-1582
pubmed: 28968859
J Diabetes Metab Disord. 2021 Jan 07;20(1):1-5
pubmed: 34222056

Auteurs

Sokhna Ndongo (S)

MEPHI, IHU Méditerranée Infection, Aix Marseille University, 19-21 Boulevard Jean Moulin, 13005, Marseille, France. sokhnandongo@gmail.com.
IHU-Méditerranée Infection, Marseille, France. sokhnandongo@gmail.com.

Nicholas Armstrong (N)

IHU-Méditerranée Infection, Marseille, France.
IRD, AP-HM, SSA, VITROME, IHU-Méditerranée Infection, Aix Marseille University, Marseille, France.

Didier Raoult (D)

MEPHI, IHU Méditerranée Infection, Aix Marseille University, 19-21 Boulevard Jean Moulin, 13005, Marseille, France.
IHU-Méditerranée Infection, Marseille, France.
Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.

Pierre-Edouard Fournier (PE)

IHU-Méditerranée Infection, Marseille, France. pierre-edouard.fournier@univ-amu.fr.
IRD, AP-HM, SSA, VITROME, IHU-Méditerranée Infection, Aix Marseille University, Marseille, France. pierre-edouard.fournier@univ-amu.fr.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH